Cancer patients get continued access to promising drug in extension study
NCT ID NCT05112965
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study offers continued access to the cancer drug atezolizumab for people who were already benefiting from it in a previous Roche-sponsored trial. It includes 49 participants who need ongoing treatment and do not have local access to the drug. The main goal is to provide uninterrupted therapy while monitoring for serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital
Beijing, 100142, China
-
Cancer Hospital of Shandong First Medical University
Jinan, Shandong, 250117, China
-
Changchun Cancer Hospital
Changchun, 130000, China
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 150081, China
-
Henan Cancer Hospital
Zhengzhou, 450008, China
-
Hunan Cancer Hospital
Changsha, 410013, China
-
Jiangsu Cancer Hospital
Nanjing, 211100, China
-
Jilin Cancer Hospital
Changchun, 132013, China
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Peking Union Medical College Hospital
Beijing, 100730, China
-
Shanghai Chest Hospital
Shanghai, 200000, China
-
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, 310016, China
-
The 2nd Hospital of Tianjin Medical University
Tianjin, 300211, China
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, 510120, China
-
Tianjin Cancer Hospital
Tianjin, 300060, China
-
Union Hospital of Tongji Medical College, Dept. of Cancer Center
Wuhan, Hubei, 430022, China
-
Zhejiang Cancer Hospital
Zhejiang, 310022, China
Conditions
Explore the condition pages connected to this study.